Package 0187-0731-07

Brand: wellbutrin xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0187-0731-07
Digits Only 0187073107
Product NDC 0187-0731
Description

7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-07)

Marketing

Marketing Status
Marketed Since 2003-08-29
Brand wellbutrin xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "22308f71-fc56-430d-b559-bed47e17a46c", "openfda": {"upc": ["0301870730302", "0301870731309"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993545", "993557", "993564"], "spl_set_id": ["a435da9d-f6e8-4ddc-897d-8cd2bf777b21"], "manufacturer_name": ["Bausch Health US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-07)", "package_ndc": "0187-0731-07", "marketing_start_date": "20030829"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0731-30)", "package_ndc": "0187-0731-30", "marketing_start_date": "20030829"}], "brand_name": "WELLBUTRIN XL", "product_id": "0187-0731_22308f71-fc56-430d-b559-bed47e17a46c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0187-0731", "generic_name": "bupropion hydrochloride", "labeler_name": "Bausch Health US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "WELLBUTRIN", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "NDA021515", "marketing_category": "NDA", "marketing_start_date": "20030829", "listing_expiration_date": "20271231"}